Ro Subscription Review: How the GLP-1 Membership Works

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Welcome to the PlexusDx Education Hub, where we unpack GLP-1 programs, weight-management protocols, and the genetic factors that sit beneath every metabolic plan. Browse all Peptides & GLP-1 education

This is an independent editorial review written without any commercial tie to Ro. PlexusDx earns no affiliate revenue and receives no compensation from Roman Health for this coverage.

Search interest in a "Ro subscription" usually comes down to one practical question: what are you actually signing up for each month? This review breaks down how the membership model is structured, what recurring billing covers, and one metabolic input the subscription never measures. Fair-balance framing, not a purchase recommendation. As of April 2026.

How Ro structures its subscription

Ro (Roman Health) runs on a subscription-telehealth model rather than a one-time visit. In practice that means a recurring relationship: an initial virtual evaluation by a licensed clinician, an ongoing prescription routed to either a retail pharmacy for FDA-approved brand products or a 503A compounding pharmacy for compounded semaglutide or tirzepatide, and continued follow-up between refills. Program structure and current terms live on Ro's official website.

What a telehealth membership actually bundles

The word "subscription" can hide several separate line items. In most telehealth GLP-1 memberships, a monthly fee covers clinical access — provider messaging, dose adjustments, and follow-up — while the medication itself may be billed separately or folded into the plan depending on whether it is a branded product or a compounded preparation. Reading which components are bundled versus billed on top is the difference between a headline price and your true monthly spend.

Billing cadence, refills, and cancellation realities

Recurring models share a few mechanics worth understanding before you enroll.

Recurring billing

Subscription plans typically charge on a fixed monthly or multi-month cycle. Longer prepaid intervals sometimes lower the effective monthly figure, but they also commit you further in advance, so the cadence, not just the sticker number, shapes what you pay.

Auto-refill and dose titration

Because GLP-1 protocols step up over time, refills are often synchronized to a titration schedule and shipped automatically. That convenience is the point of a subscription, but it also means shipments continue until you actively change the plan.

Pausing or canceling

Cancellation terms, pause options, and refund windows are set by the provider and appear in the membership agreement. Confirm them on Ro's own site before enrolling, since these details change and vary by state.

The compound class behind subscription GLP-1 plans

Whatever the billing wrapper, the pharmacology is the same drug class. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide are the compounds these programs prescribe. Their evidence base comes from trial programs such as STEP (semaglutide for weight management, published in The New England Journal of Medicine, 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Trial populations and endpoints differ, and individual outcomes vary.

The subscription blind spot: your genetics aren't in the plan

A subscription can automate billing and refills, but it cannot describe the metabolic terrain a GLP-1 compound is prescribed into, and that terrain is partly genetic. Variants in FTO (fat-mass and obesity-associated), GLP1R (the GLP-1 receptor itself), MC4R (a satiety and energy-balance receptor), and TCF7L2 (tied to glucose regulation and GLP-1 secretion) map baseline biology at the pathway level. They do not predict how you will respond to any specific drug, but they describe the system a clinician is prescribing into. Before starting any GLP-1 protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including those variants — so the plan you subscribe to starts from real context rather than guesswork.

Where PlexusDx fits for subscription shoppers

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — including Semaglutide Injection at $189/mo and Tirzepatide Injection at $289/mo, plus oral options and a $129/mo microdose plan — with pricing shown up front rather than only after intake. The Precision Peptide Genetic Test is $298. The distinction is not the subscription mechanics; it is pairing the protocol with upstream pathway context most telehealth memberships leave out.

Not affiliated: PlexusDx has no affiliation or commercial relationship with Ro or the other companies referenced here.

Related reading on PlexusDx: GLP-1 What Is, GLP-1 Receptor Agonist, GLP-1 Drugs, GLP-1 Hormone.

Editorial note: This article is educational and independent. PlexusDx is not affiliated with Ro and sells semaglutide and tirzepatide through its own Weight Management Protocols, so treat this as a comparison of approaches within GLP-1 telehealth. The Precision Peptide Genetic Test reports how your genes influence peptide-related pathways; it does not predict response to any specific medication. Speak with a qualified healthcare provider before starting any peptide protocol.

Frequently Asked Questions about Ro subscriptions

What am I actually subscribing to with Ro?

Most telehealth GLP-1 subscriptions bundle recurring clinical access — provider messaging, follow-up, and dose management — with medication that may be billed within or on top of the plan. Check Ro's own membership terms to see which components are included before enrolling, since structures differ by product and by state.

Can I cancel a Ro subscription?

Cancellation, pause, and refund terms are defined by the provider and listed in the membership agreement, not set universally across telehealth. They also shift over time and by state. Review the current policy on Ro's official website before you sign up so the commitment matches your expectations.

Does the subscription price include the medication?

It depends on the plan. Some memberships fold medication cost into the monthly fee, while others separate the clinical subscription from pharmacy charges, especially when a compounded preparation is involved. The only reliable source is Ro's published pricing, which changes frequently, so confirm the breakdown before committing.

Do I need a subscription to take the Precision Peptide Genetic Test?

No. The Precision Peptide Genetic Test is a one-time analysis of pathway-level variants such as FTO, MC4R, and TCF7L2, independent of any subscription. It provides upstream genetic context that applies no matter which telehealth service, if any, ultimately prescribes a GLP-1 compound for you.

Explore more in the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.